151 related articles for article (PubMed ID: 8796706)
1. Magnetic resonance imaging detection of extraluminal enterally administered gadopentetate dimeglumine in a rat model of intestinal ischemia.
Montalbano JM; Lee FT; Grist TM; Rappe AH; Weiss JW; Kelcz F; Gribenko V
Acad Radiol; 1996 Jun; 3(6):486-92. PubMed ID: 8796706
[TBL] [Abstract][Full Text] [Related]
2. Early MR detection of experimentally induced cerebral ischemia using magnetic susceptibility contrast agents: comparison between gadopentetate dimeglumine and iron oxide particles.
Reith W; Forsting M; Vogler H; Heiland S; Sartor K
AJNR Am J Neuroradiol; 1995 Jan; 16(1):53-60. PubMed ID: 7900602
[TBL] [Abstract][Full Text] [Related]
3. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
Strouse PJ; Prince MR; Chenevert TL
Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
Jung HW; Chang KH; Choi DS; Han MH; Han MC
AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
[TBL] [Abstract][Full Text] [Related]
5. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
Campos A; Aznar L; Alamar R; Castelló JV
Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
[No Abstract] [Full Text] [Related]
6. Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
Fujita T; Ito K; Choji T; Honjo K; Matsumoto T; Arita T; Nakanishi T
AJR Am J Roentgenol; 1994 Oct; 163(4):865-6. PubMed ID: 8092025
[No Abstract] [Full Text] [Related]
7. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW
AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583
[TBL] [Abstract][Full Text] [Related]
8. Chemical shift misregistration artifact: increased conspicuity following intravenous administration of gadopentetate dimeglumine.
Apicella PL; Mirowitz SA; Borrello JA
Magn Reson Imaging; 1994; 12(4):675-8. PubMed ID: 8057773
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cardiovascular changes after administration of gadodiamide injection and gadopentetate dimeglumine in dogs.
Bøkenes J; Hustvedt SO; Refsum H
Acad Radiol; 1997 Mar; 4(3):204-9. PubMed ID: 9084778
[TBL] [Abstract][Full Text] [Related]
10. [Gadolinium-DTPA dimeglumine administered orally for the study of the abdomen with magnetic resonance. Clinical evaluation and tolerance].
Squillaci E; Crecco M; Cecconi L; Lupoi D; Sergiacomi GL; Simonetti G
Radiol Med; 1993 Sep; 86(3):284-93. PubMed ID: 8210538
[TBL] [Abstract][Full Text] [Related]
11. Differentiating between T1 and T2* changes caused by gadopentetate dimeglumine in the kidney by using a double-echo dynamic MR imaging sequence.
Kuperman VY; Karczmar GS; Blomley MJ; Lewis MZ; Lubich LM; Lipton MJ
J Magn Reson Imaging; 1996; 6(5):764-8. PubMed ID: 8890014
[TBL] [Abstract][Full Text] [Related]
12. Lumbosacral spine: early and delayed MR imaging after administration of an expanded dose of gadopentetate dimeglumine in healthy, asymptomatic subjects.
Jinkins JR; Rauch RA; Gee GT; Bazan C; Xiong L; Kashanian FK; Hanna EP
Radiology; 1995 Oct; 197(1):247-51. PubMed ID: 7568831
[TBL] [Abstract][Full Text] [Related]
13. Clinical safety of gadopentetate dimeglumine.
Nelson KL; Gifford LM; Lauber-Huber C; Gross CA; Lasser TA
Radiology; 1995 Aug; 196(2):439-43. PubMed ID: 7617858
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of joint fluid with intravenously administered gadopentetate dimeglumine: technique, rationale, and implications.
Winalski CS; Aliabadi P; Wright RJ; Shortkroff S; Sledge CB; Weissman BN
Radiology; 1993 Apr; 187(1):179-85. PubMed ID: 8451409
[TBL] [Abstract][Full Text] [Related]
15. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
[TBL] [Abstract][Full Text] [Related]
16. Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findings.
Roman-Goldstein SM; Barnett PA; McCormick CI; Ball MJ; Ramsey F; Neuwelt EA
AJNR Am J Neuroradiol; 1991; 12(5):885-90. PubMed ID: 1950917
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of gadodiamide injection and gadopentetate dimeglumine in anesthetized dogs.
Peters JL; Shaw DD
Acta Radiol; 1993 Sep; 34(5):510-6. PubMed ID: 8369191
[TBL] [Abstract][Full Text] [Related]
18. Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
Tishler S; Hoffman JC
AJNR Am J Neuroradiol; 1990; 11(6):1167; discussion 1168-9. PubMed ID: 2124049
[No Abstract] [Full Text] [Related]
19. MR assessment of radiation-induced blood-brain barrier permeability changes in rat glioma model.
Krueck WG; Schmiedl UP; Maravilla KR; Spence AM; Starr FL; Kenney J
AJNR Am J Neuroradiol; 1994 Apr; 15(4):625-32. PubMed ID: 8010261
[TBL] [Abstract][Full Text] [Related]
20. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]